RXRX Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range

03

Price $4.12

Market Cap (MRQ) $2.20B

P/E (TTM) -4.1

EPS (TTM) $-1.00

Revenue (TTM) $55M

ROE (TTM) -56.6%

52W Range $3–$7

RXRX Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view

04

range

bars

Bar granularity adapts to the selected period — hover the chart to see open/high/low/close for a bar.

10-Year Performance Revenue, net income, margins and EPS trends

06

Revenue$75M

2019-12-31 → 2025-12-31

EPS$-1.44

2019-12-31 → 2025-12-31

Free Cash Flow$-378M

2021-12-31 → 2025-12-31

Net margin-945.9%

2021-12-31 → 2025-12-31

Valuation & Ratios 07–12

Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?

Metric	RXRX	5Y avg	Peer Median	Verdict
P/E (TTM)	-4.15Y avg ≈-6.0	≈-6.0	·	·
P/S (TTM)	40.15Y avg ≈90.0	≈90.0	29.2	Overvalued
P/B (MRQ)	2.45Y avg ≈3.6	≈3.6	4.6	Undervalued
Price / FCF (TTM)	-6.25Y avg ≈-9.5	≈-9.5	·	·
Price / Cash Flow (TTM)	-6.35Y avg ≈-11.5	≈-11.5	·	·
Price / Tangible Book (MRQ)	3.55Y avg ≈4.6	≈4.6	·	·

Peer median is calculated on a standardized basis per metric and may not always match the TTM/MRQ basis shown for this stock.

Profitability Gross, operating and net margins; ROE, ROA, ROIC

Metric	RXRX	5Y avg	Peer Median	Verdict
Operating Margin (TTM)	-991.7%5Y avg ≈-976.0%	≈-976.0%	-1400.7%	Below avg
EBITDA Margin (TTM)	-848.9%5Y avg ≈-907.8%	≈-907.8%	-1400.7%	Below avg
Pretax Margin (TTM)	-954.3%5Y avg ≈-799.5%	≈-799.5%	6.3%	Weak
Net Profit Margin (TTM)	-945.9%5Y avg ≈-964.1%	≈-964.1%	-1349.1%	Below avg
ROA (TTM)	-41.3%5Y avg ≈-42.8%	≈-42.8%	-40.3%	Weak
ROE (TTM)	-56.6%5Y avg ≈-56.5%	≈-56.5%	-54.5%	Weak
ROIC	-57.3%5Y avg ≈-59.4%	≈-59.4%	-52.2%	Weak

Financial Health Debt, liquidity, solvency — balance sheet strength

Metric	5Y trend	RXRX	5Y avg	Peer Median	Verdict
Current Ratio (MRQ)		5.05Y avg ≈6.2	≈6.2	8.9	Low liquidity
Quick Ratio		5.05Y avg ≈5.8	≈5.8	5.3	In line

Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR

Metric	RXRX	5Y avg	Peer Median	Verdict
Revenue YoY	26.9%5Y avg ≈103.8%	≈103.8%	·	·
Revenue CAGR 3Y	23.3%5Y avg ≈75.6%	≈75.6%	·	·
Revenue CAGR 5Y	79.9%	·	·	·

Per Share Metrics EPS, book value per share, cash flow per share, dividend per share

Metric	RXRX	5Y avg	Peer Median	Verdict
EPS (Diluted)	$-1.445Y avg ≈$-1.51	≈$-1.51	·	·
Revenue / Share	$0.175Y avg ≈$0.18	≈$0.18	·	·
Cash Flow / Share	$-0.835Y avg ≈$-1.05	≈$-1.05	·	·
Cash / Share	$1.415Y avg ≈$1.83	≈$1.83	·	·

Capital Efficiency Asset turnover, inventory turnover, receivables turnover

Metric	5Y trend	RXRX	5Y avg	Peer Median	Verdict
Asset Turnover		0.15Y avg ≈0.1	≈0.1	0.1	Weak
Revenue / Employee		≈$124.5K	·	·	·

value · ≈ 5Y avg · industry median · verdict relative to median

Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date

14

Avg Surprise 7.8%

Next Report Nov 03, 2026

Period	Report	EPS Actual	EPS Est	Surprise
June 30, 2026	Aug 11, 2026	$-0.25	$-0.24	-4.7%
March 31, 2026		$-0.22	$-0.28	20.5%
Dec. 31, 2025		$-0.21	$-0.32	34.8%
Sept. 30, 2025		$-0.36	$-0.38	4.6%
June 30, 2025		$-0.41	$-0.36	-14.8%
March 31, 2025		$-0.50	$-0.54	6.6%

Full Fundamentals All metrics by year — income statement, balance sheet, cash flow

15

Income Statement 16

Metric	2025	2024	2023	2022	2021	2020	2019
Revenue	$75M	$59M	$45M	$40M	$10M	$4M	$2M
Cost of Revenue	$71M	$45M	$43M	$48M	$0	$0	·
R&D Expense	$475M	$314M	$241M	$156M	$135M	$63M	$46M
SG&A Expense	$177M	$178M	$111M	$82M	$58M	$25M	$19M
Operating Expenses	$723M	$538M	$395M	$286M	$193M	$89M	$65M
Operating Income	$-648M	$-479M	$-350M	$-246M	$-183M	$-85M	$-62M
Interest Expense	·	·	$97.0K	$55.0K	$3M	$1M	$635.0K
Other Non-op	$3M	$14M	$18M	$6M	$-4M	$-2M	$562.0K
Pretax Income	$-645M	$-465M	$-332M	$-239M	$-186M	·	·
Income Tax	$-136.0K	$-1M	$-4M	$0	$0	$0	$0
Net Income	$-645M	$-464M	$-328M	$-239M	$-186M	$-87M	$-62M
EPS (Basic)	$-1.44	$-1.69	$-1.58	$-1.36	$-1.49	$-3.99	$-2.87
EPS (Diluted)	$-1.44	$-1.69	$-1.58	$-1.36	$-1.49	$-3.99	$-2.87
Shares (Basic)	447,446,109	274,207,146	207,853,702	175,537,487	125,348,110	21,781,386	21,570,265
Shares (Diluted)	447,446,109	274,207,146	207,853,702	175,537,487	125,348,110	21,781,386	21,570,265
EBITDA	$-564M	$-443M	$-326M	$-234M	$-174M	·	·

Balance Sheet 30

Metric	2025	2024	2023	2022	2021	2020	2019
Cash & Equivalents	$743M	$594M	$392M	$550M	$285M	$262M	·
Short-term Investments	·	·	·	$0	$231M	$0	·
Receivables	·	·	·	$0	$34.0K	$156.0K	·
Prepaid Expense	$12M	$30M	·	·	·	·	·
Other Current Assets	$29M	$38M	$40M	$16M	$8M	$2M	·
Current Assets	$813M	$714M	$438M	$570M	$535M	$266M	·
PP&E (Net)	$104M	$141M	$87M	$88M	$65M	$26M	·
PP&E (Gross)	$193M	$204M	$131M	$118M	$83M	$36M	·
Accum. Depreciation	$89M	$63M	$45M	$30M	$19M	$10M	·
Goodwill	$162M	$149M	$52M	$801.0K	$801.0K	$801.0K	·
Intangibles	$310M	$336M	$36M	$1M	$1M	$2M	·
Other Non-current Assets	$13M	$9M	$261.0K	$0	$35.0K	$650.0K	·
Total Assets	$1.47B	$1.45B	$654M	$701M	$610M	$299M	·
Accounts Payable	$18M	$22M	$4M	$5M	$3M	$1M	·
Accrued Liabilities	$70M	$82M	$47M	$33M	$32M	$10M	·
Short-term Debt	·	·	$41.0K	$97.0K	$90.0K	$1M	·
Current Liabilities	$148M	$187M	$93M	$100M	$47M	$23M	·
Capital Leases	$47M	$67M	$43M	$44M	$0	·	·
Deferred Tax	$23M	$17M	$1M	$0	·	·	·
Other Non-current Liabilities	$2M	$5M	$0	·	·	·	·
Total Liabilities	$343M	$414M	$190M	$215M	$67M	$57M	·
Long-term Debt	·	·	·	·	$723.0K	·	·
Total Debt	·	·	$41.0K	$97.0K	$90.0K	·	·
Common Stock	$5.0K	$4.0K	$2.0K	$2.0K	$2.0K	$0	·
Paid-in Capital	$3.17B	$2.47B	$1.43B	$1.13B	$943M	$7M	·
Retained Earnings	$-2.08B	$-1.43B	$-968M	$-640M	$-400M	$-214M	·
AOCI	$37M	$-8M	$0	$0	$-126.0K	$0	·
Stockholders' Equity	$1.13B	$1.03B	$463M	$486M	$543M	$-206M	$-124M
Liabilities + Equity	$1.47B	$1.45B	$654M	$701M	$610M	$299M	·
Shares Outstanding	528,182,693	396,802,394	234,270,384	191,022,864	170,272,462	22,314,685	21,637,609

Cash Flow 17

Metric	2025	2024	2023	2022	2021	2020	2019
D&A	$84M	$36M	$24M	$12M	$8M	$4M	$2M
Stock-based Comp	$111M	$82M	$54M	$28M	$15M	$4M	$1M
Deferred Tax	$-368.0K	$-2M	$-4M	$0	·	·	·
Amort. of Intangibles	$50M	$19M	$8M	$379.0K	$304.0K	$126.0K	$0
Restructuring	$10M	·	·	·	·	·	·
Other Non-cash	$78M	$-12M	$-38M	$116M	$5M	·	·
Operating Cash Flow	$-372M	$-359M	$-288M	$-84M	$-159M	$-45M	$-57M
CapEx	$6M	$14M	$12M	$37M	$40M	$6M	$4M
Investing Cash Flow	$-17M	$260M	$-10M	$193M	$-272M	$-9M	$-4M
Net Debt Issued	·	·	$-766.0K	$-90.0K	$-13M	·	·
Stock Issued	$529M	$300M	$128M	$144M	$463M	$0	·
Net Stock Activity	$529M	$300M	$128M	$144M	·	·	·
Financing Cash Flow	$522M	$304M	$140M	$154M	$459M	$246M	$120M
Net Change in Cash	$151M	$202M	$-158M	$264M	$28M	$192M	$59M
Taxes Paid	$237.0K	$0	·	·	·	·	·
Free Cash Flow	$-378M	$-373M	$-300M	$-121M	$-198M	·	·
Levered FCF	·	·	$-300M	·	·	·	·

Profitability 7

Metric	2025	2024	2023	2022	2021	2020	2019
Operating Margin	-867.9%	-814.1%	-785.3%	-616.7%	-1795.8%	·	·
Net Margin	-863.4%	-788.0%	-736.0%	-601.1%	-1832.2%	·	·
Pretax Margin	-863.5%	-789.9%	-745.1%	·	·	·	·
EBITDA Margin	-755.8%	-752.1%	-730.6%	-587.2%	-1713.2%	·	·
ROA	-44.1%	-44.1%	-48.4%	-36.5%	-41.0%	·	·
ROE	-62.9%	-59.5%	-72.8%	-54.8%	-32.7%	·	·
ROIC	-57.3%	-46.2%	-74.6%	·	·	·	·

Liquidity & Solvency 4

Metric	2025	2024	2023	2022	2021	2020	2019
Current Ratio	5.5	3.8	4.7	5.7	11.5	·	·
Quick Ratio	5.0	3.2	4.2	5.5	11.1	·	·
Debt / Equity	·	·	0.0	0.0	0.0	·	·
Interest Coverage	·	·	-3608.9	-4467.8	-61.9	·	·

Efficiency 2

Metric	Trend	2025	2024	2023	2022	2021	2020	2019
Asset Turnover		0.1	0.1	0.1	0.1	0.0	·	·
Receivables Turnover		·	·	·	2343.7	107.1	·	·

Per Share 5

Metric	2025	2024	2023	2022	2021	2020	2019
Book Value / Share	$2.14	$2.61	$1.98	$2.54	$3.19	·	·
Revenue / Share	$0.17	$0.21	$0.21	$0.23	$0.08	·	·
Cash Flow / Share	$-0.83	$-1.31	$-1.38	$-0.48	$-1.27	·	·
Cash / Share	$1.41	$1.50	$1.67	$2.88	$1.67	·	·
EPS (TTM)	$-1.44	$-1.69	$-1.58	$-1.36	$-1.49	·	·

Growth Rates 3

Metric	2025	2024	2023	2022	2021	2020	2019
Revenue YoY	26.9%	32.0%	11.9%	291.5%	156.9%	·	·
Revenue CAGR 3Y	23.3%	79.5%	124.1%	·	·	·	·
Revenue CAGR 5Y	79.9%	·	·	·	·	·	·

Valuation (TTM) 14

Metric	2025	2024	2023	2022	2021	2020	2019
Revenue TTM	$75M	$59M	$45M	$40M	$10M	·	·
Net Income TTM	$-645M	$-464M	$-328M	$-239M	$-186M	·	·
Market Cap	$2.16B	$2.68B	$2.31B	$1.47B	$2.92B	·	·
Enterprise Value	·	·	$1.92B	$923M	$2.40B	·	·
P/E	-2.8	-4.0	-6.2	-5.7	-11.5	·	·
P/S	28.9	45.6	51.8	37.0	286.6	·	·
P/B	1.9	2.6	5.0	3.0	5.4	·	·
P / Tangible Book	3.3	4.9	6.2	3.0	5.4	·	·
P / Cash Flow	-5.8	-7.5	-8.0	-17.6	-18.4	·	·
P / FCF	-5.7	-7.2	-7.7	-12.2	-14.7	·	·
EV / EBITDA	·	·	-5.9	-3.9	-13.8	·	·
EV / FCF	·	·	-6.4	-7.7	-12.1	·	·
EV / Revenue	·	·	43.0	23.2	235.8	·	·
Earnings Yield	-35.2%	-25.0%	-16.0%	-17.6%	-8.7%	·	·

Income Statement 16

Metric	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Revenue	$8M	$6M	$36M	$5M	$19M	$15M	$5M	$26M	$14M	$14M	$11M	$11M	$11M	$12M	$14M	$13M
Cost of Revenue	$11M	$12M	$14M	$15M	$20M	$22M	$13M	$12M	$9M	$11M	$10M	$11M	$9M	$12M	$11M	$15M
R&D Expense	$90M	$88M	$96M	$121M	$129M	$130M	$98M	$75M	$74M	$68M	$69M	$70M	$55M	$47M	$44M	$41M
SG&A Expense	$42M	$35M	$34M	$42M	$47M	$55M	$77M	$38M	$32M	$31M	$30M	$29M	$28M	$23M	$20M	$19M
Operating Expenses	$143M	$135M	$144M	$177M	$195M	$206M	$188M	$124M	$115M	$110M	$110M	$110M	$93M	$82M	$75M	$76M
Operating Income	$-135M	$-129M	$-108M	$-172M	$-176M	$-191M	$-184M	$-98M	$-101M	$-96M	$-99M	$-100M	$-82M	$-70M	$-61M	$-63M
Interest Expense	·	·	·	·	·	·	·	·	·	$20.0K	·	$25.0K	$26.0K	$19.0K	·	$13.0K
Other Non-op	$4M	$6M	$232.0K	$10M	$4M	$-11M	$5M	$3M	$2M	$4M	$2M	$7M	$5M	$5M	$3M	$2M
Pretax Income	$-131M	$-122M	$-108M	$-162M	$-172M	$-203M	$-179M	$-96M	$-98M	$-92M	$-97M	$-93M	$-77M	$-65M	·	·
Income Tax	$-1.0K	$-5M	$19.0K	$3.0K	$0	$-158.0K	$8.0K	$167.0K	$-523.0K	$-779.0K	$-4M	$0	$0	$0	$0	$0
Net Income	$-131M	$-118M	$-108M	$-162M	$-172M	$-202M	$-179M	$-96M	$-98M	$-91M	$-93M	$-93M	$-77M	$-65M	$-57M	$-60M
EPS (Basic)	$-0.25	$-0.22	$-0.17	$-0.36	$-0.41	$-0.50	$-0.56	$-0.34	$-0.40	$-0.39	$-0.43	$-0.43	$-0.38	$-0.34	$-0.30	$-0.35
EPS (Diluted)	$-0.25	$-0.22	$-0.17	$-0.36	$-0.41	$-0.50	$-0.56	$-0.34	$-0.40	$-0.39	$-0.43	$-0.43	$-0.38	$-0.34	$-0.30	$-0.35
Shares (Basic)	532,460,085	529,303,984	·	446,988,046	417,361,147	402,771,972	·	282,583,048	242,196,409	236,019,349	·	214,327,186	201,415,475	191,618,238	·	173,435,970
Shares (Diluted)	532,460,085	529,303,984	·	446,988,046	417,361,147	402,771,972	·	282,583,048	242,196,409	236,019,349	·	214,327,186	201,415,475	191,618,238	·	173,435,970
EBITDA	$-135M	$-109M	·	$-172M	$-176M	$-172M	·	$-98M	$-101M	$-89M	·	$-100M	$-82M	$-66M	·	$-63M

Balance Sheet 29

Metric	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Cash & Equivalents	$546M	$654M	$743M	$660M	$525M	$500M	$594M	$428M	$474M	$296M	·	$387M	$406M	$473M	·	$455M
Short-term Investments	·	·	·	·	·	·	·	·	·	·	·	·	·	·	·	$0
Receivables	·	·	·	·	·	·	·	·	·	·	·	·	·	·	·	$0
Prepaid Expense	$9M	$12M	$12M	$0	$0	$2M	$30M	·	·	·	·	·	·	·	·	·
Other Current Assets	$29M	$24M	$29M	$29M	$37M	$32M	$38M	$43M	$44M	$41M	·	$18M	$19M	$16M	·	$13M
Current Assets	$603M	$710M	$813M	$714M	$587M	$584M	$714M	$474M	$522M	$344M	·	$411M	$431M	$492M	·	$482M
PP&E (Net)	$90M	$96M	$104M	$112M	$120M	$127M	$141M	$84M	$84M	$87M	·	$86M	$90M	$90M	·	$86M
PP&E (Gross)	·	·	$193M	·	·	·	$204M	$141M	$136M	$136M	·	$127M	$127M	$124M	·	$113M
Accum. Depreciation	·	·	$89M	·	·	·	$63M	$56M	$52M	$49M	·	$41M	$38M	$34M	·	$27M
Goodwill	$160M	$160M	$162M	$162M	$164M	$158M	$149M	$52M	$52M	$52M	$52M	$53M	$61M	$801.0K	$801.0K	$801.0K
Intangibles	$283M	$294M	$310M	$322M	$341M	$336M	$336M	$34M	$38M	$33M	·	$39M	$43M	$1M	·	$1M
Other Non-current Assets	$12M	$12M	$13M	$15M	$9M	$15M	$9M	$360.0K	$308.0K	$254.0K	·	$155.0K	$110.0K	$82.0K	·	$0
Total Assets	$1.21B	$1.34B	$1.47B	$1.40B	$1.30B	$1.31B	$1.45B	$726M	$776M	$558M	·	$631M	$667M	$627M	·	$612M
Accounts Payable	$13M	$20M	$18M	$14M	$19M	$25M	$22M	$2M	$4M	$5M	·	$4M	$2M	$4M	·	$4M
Accrued Liabilities	$57M	$54M	$70M	$53M	$64M	$57M	$82M	$41M	$33M	$26M	·	$40M	$33M	$25M	·	$27M
Short-term Debt	·	·	·	·	·	·	·	·	·	$55.0K	·	$695.0K	$676.0K	$661.0K	·	$95.0K
Current Liabilities	$120M	$130M	$148M	$155M	$164M	$142M	$187M	$109M	$86M	$74M	·	$94M	$114M	$92M	·	$83M
Capital Leases	$39M	$43M	$47M	$50M	$53M	$56M	$67M	$54M	$50M	$44M	·	$44M	$46M	$47M	·	$46M
Deferred Tax	$18M	$18M	$23M	$23M	$24M	$22M	$17M	$168.0K	$0	$528.0K	·	$2M	$4M	·	·	·
Other Non-current Liabilities	$3M	$2M	$2M	$1M	$2M	$5M	$5M	$3M	$3M	·	·	·	·	·	·	·
Total Liabilities	$298M	$315M	$343M	$353M	$383M	$371M	$414M	$202M	$191M	$157M	·	$193M	$198M	$197M	·	$223M
Total Debt	·	·	·	·	·	·	·	·	·	$55.0K	·	$695.0K	$676.0K	$661.0K	·	$95.0K
Common Stock	$5.0K	$5.0K	$5.0K	$5.0K	$4.0K	$4.0K	$4.0K	$3.0K	$3.0K	$2.0K	·	$2.0K	$2.0K	$2.0K	·	$2.0K
Paid-in Capital	$3.21B	$3.19B	$3.17B	$2.98B	$2.68B	$2.55B	$2.47B	$1.78B	$1.74B	$1.46B	·	$1.31B	$1.25B	$1.14B	·	$970M
Retained Earnings	$-2.32B	$-2.19B	$-2.08B	$-1.97B	$-1.81B	$-1.63B	$-1.43B	$-1.25B	$-1.16B	$-1.06B	·	$-875M	$-782M	$-705M	·	$-582M
AOCI	$28M	$27M	$37M	$34M	$44M	$14M	$-8M	·	·	·	·	·	·	·	·	$0
Stockholders' Equity	$915M	$1.02B	$1.13B	$1.05B	$919M	$934M	$1.03B	$525M	$584M	$401M	$463M	$438M	$469M	$430M	$486M	$388M
Liabilities + Equity	$1.21B	$1.34B	$1.47B	$1.40B	$1.30B	$1.31B	$1.45B	$726M	$776M	$558M	·	$631M	$667M	$627M	·	$612M
Shares Outstanding	534,120,235	530,628,653	528,182,693	491,800,501	432,830,642	406,410,733	396,802,394	286,124,279	280,968,276	237,508,682	234,270,384	216,313,682	206,737,332	192,230,854	191,022,864	174,072,906

Cash Flow 16

Metric	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
D&A	$18M	$20M	$19M	$21M	$24M	$19M	$13M	$7M	$9M	$7M	$8M	$8M	$6M	$4M	$3M	$3M
Stock-based Comp	$19M	$22M	$24M	$25M	$26M	$36M	$31M	$18M	$17M	$16M	$16M	$17M	$12M	$9M	$8M	$9M
Deferred Tax	$-3.0K	$-5M	·	·	$638.0K	$-419.0K	·	·	·	·	·	·	·	·	·	·
Amort. of Intangibles	$12M	$13M	$13M	$13M	$12M	$12M	$7M	$4M	$4M	$3M	$3M	$3M	$2M	$152.0K	$151.0K	$76.0K
Restructuring	·	·	$1M	$73.0K	·	·	·	·	·	·	·	·	·	·	·	·
Other Non-cash	·	$-888.0K	·	·	·	$15M	·	·	·	$-34M	·	·	·	$-21M	·	·
Operating Cash Flow	$-106M	$-81M	$-46M	$-117M	$-76M	$-132M	$-115M	$-59M	$-82M	$-102M	$-74M	$-73M	$-67M	$-73M	$-45M	$-55M
CapEx	$44.0K	$258.0K	$1M	$243.0K	$3M	$2M	$1M	$5M	$1M	$7M	$2M	$745.0K	$4M	$5M	$8M	$8M
Investing Cash Flow	$-2M	$-338.0K	$-1M	$-3M	$-6M	$-7M	$275M	$-5M	$-4M	$-7M	$-2M	$-347.0K	$-2M	$-5M	$-8M	$53M
Net Debt Issued	·	·	·	·	·	·	·	·	·	$-26.0K	·	·	·	$-24.0K	·	·
Stock Issued	$0	$0	$133M	$254M	$100M	$41M	$11M	$17M	$262M	$11M	$78M	$50M	$0	$0	·	·
Net Stock Activity	·	$0	·	·	·	$41M	·	·	·	$11M	·	·	·	·	·	·
Financing Cash Flow	$-1M	$-3M	$132M	$251M	$98M	$41M	$11M	$16M	$263M	$14M	$81M	$54M	$4M	$2M	$147M	$2M
Net Change in Cash	$-108M	$-89M	$87M	$133M	$25M	$-94M	$167M	$-47M	$177M	$-95M	$4M	$-20M	$-66M	$-77M	$94M	$780.0K
Free Cash Flow	·	$-81M	·	·	·	$-134M	·	·	·	$-109M	·	·	·	$-78M	·	·
Levered FCF	·	·	·	·	·	·	·	·	·	$-109M	·	·	·	·	·	·

Profitability 7

Metric	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Operating Margin	-1759.7%	-1985.5%	·	-3327.6%	-916.8%	-1297.9%	·	-377.1%	-697.4%	-698.4%	·	-945.1%	-741.7%	-575.8%	·	-475.5%
Net Margin	-1708.0%	-1815.6%	·	-3135.3%	-894.2%	-1373.3%	·	-367.5%	-676.6%	-662.4%	·	-883.1%	-696.4%	-538.4%	·	-459.3%
Pretax Margin	-1708.0%	-1886.7%	·	-3135.3%	-894.2%	-1374.3%	·	-366.8%	-680.2%	-668.1%	·	·	·	·	·	·
EBITDA Margin	-1759.7%	-1681.6%	·	-3327.6%	-916.8%	-1166.8%	·	-377.1%	-697.4%	-644.9%	·	-945.1%	-741.7%	-545.1%	·	-475.5%
ROA	-10.4%	-8.9%	·	-15.3%	-16.5%	-21.7%	·	-14.1%	-13.5%	-15.4%	·	-15.0%	-11.5%	-9.6%	·	-9.5%
ROE	-14.3%	-12.0%	·	-20.6%	-22.9%	-30.3%	·	-19.9%	-18.5%	-22.0%	·	-22.5%	-16.9%	-14.1%	·	-12.2%
ROIC	-14.8%	-12.1%	·	-16.4%	-19.2%	-20.5%	·	-18.8%	-17.1%	-23.8%	·	·	·	·	·	·

Liquidity & Solvency 4

Metric	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Current Ratio	5.0	5.5	·	4.6	3.6	4.1	·	4.4	6.1	4.6	·	4.4	3.8	5.3	·	5.8
Quick Ratio	4.6	5.0	·	4.3	3.2	3.5	·	3.9	5.5	4.0	·	4.1	3.6	5.1	·	5.5
Debt / Equity	·	·	·	·	·	·	·	·	·	0.0	·	0.0	0.0	0.0	·	0.0
Interest Coverage	·	·	·	·	·	·	·	·	·	-4817.0	·	-3982.0	-3142.9	-3677.1	·	-4813.3

Efficiency 2

Metric	Trend	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Asset Turnover		0.0	0.0	·	0.0	0.0	0.0	·	0.0	0.0	0.0	·	0.0	0.0	0.0	·	0.0
Receivables Turnover		·	·	·	·	·	·	·	·	·	·	·	·	·	·	·	774.1

Per Share 5

Metric	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Book Value / Share	$1.71	$1.93	·	$2.13	$2.12	$2.30	·	$1.83	$2.08	$1.69	·	$2.02	$2.27	$2.24	·	$2.23
Revenue / Share	$0.01	$0.01	·	$0.01	$0.05	$0.04	·	$0.09	$0.06	$0.06	·	$0.05	$0.05	$0.06	·	$0.08
Cash Flow / Share	·	$-0.15	·	·	·	$-0.33	·	·	·	$-0.43	·	·	·	$-0.38	·	·
Cash / Share	$1.02	$1.23	·	$1.34	$1.21	$1.23	·	$1.49	$1.69	$1.25	·	$1.79	$1.96	$2.46	·	$2.61
EPS (TTM)	$-1.00	$-1.16	·	$-1.83	$-1.81	$-1.80	·	$-1.56	$-1.65	$-1.63	·	$-1.45	$-1.37	$-1.37	·	$-0.63

Valuation (TTM) 11

Metric	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Revenue TTM	$55M	$66M	·	$44M	$65M	$60M	·	$65M	$50M	$46M	·	$47M	$50M	$47M	·	$29M
Net Income TTM	$-519M	$-560M	·	$-716M	$-649M	$-575M	·	$-378M	$-375M	$-354M	·	$-293M	$-260M	$-249M	·	$-247M
Market Cap	$1.96B	$1.63B	·	$2.40B	$2.19B	$2.15B	·	$1.89B	$2.11B	$2.37B	·	$1.65B	$1.54B	$1.28B	·	$1.85B
Enterprise Value	·	·	·	·	·	·	·	·	·	$2.07B	·	$1.27B	$1.14B	$810M	·	$1.40B
P/E	-3.7	-2.6	·	-2.7	-2.8	-2.9	·	-4.2	-4.5	-6.1	·	-5.3	-5.5	-4.9	·	-16.9
P/S	35.7	24.5	·	54.9	33.9	36.0	·	28.9	42.5	51.2	·	34.9	30.9	27.5	·	64.5
P/B	2.1	1.6	·	2.3	2.4	2.3	·	3.6	3.6	5.9	·	3.8	3.3	3.0	·	4.8
P / Tangible Book	4.2	2.9	·	4.3	5.3	4.9	·	4.3	4.3	7.5	·	4.8	4.2	3.0	·	4.8
P / Cash Flow	·	-20.1	·	·	·	-16.3	·	·	·	-23.1	·	·	·	-17.5	·	·
EV / Revenue	·	·	·	·	·	·	·	·	·	44.8	·	26.8	22.8	17.4	·	48.7
Earnings Yield	-27.3%	-37.8%	·	-37.5%	-35.8%	-34.0%	·	-23.7%	-22.0%	-16.4%	·	-18.9%	-18.3%	-20.5%	·	-5.9%

Most recent period on the left · null values shown as ·

Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years

16

Metric	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Revenue	$75M	$59M	$45M	$40M	$10M
Operating Margin %	-867.9%	-814.1%	-785.3%	-616.7%	-1795.8%
Net Income	$-645M	$-464M	$-328M	$-239M	$-186M
Diluted EPS	$-1.44	$-1.69	$-1.58	$-1.36	$-1.49

Metric	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Debt / Equity	·	·	0.0	0.0	0.0
Current Ratio	5.5	3.8	4.7	5.7	11.5
Quick Ratio	5.0	3.2	4.2	5.5	11.1

Metric	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Free Cash Flow	$-378M	$-373M	$-300M	$-121M	$-198M

Institutional owners (13F) 377 filers · $1.6B total · As of Sept. 30, 2026

17

Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.

Holders 377

Value held $1.6B

New positions 50

Exited positions 37

Institutional activity — Q2 2026 vs prior quarter

New positions	Exited positions	Increased	Decreased	Net shares change
50 (-21 vs prior Q)	37 (-8 vs prior Q)	134 (+4 vs prior Q)	101 (+18 vs prior Q)	+27.2M

Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.

Institution	Value	Shares	% of tracked 13F	Type
VANGUARD GROUP INC	$192,997,934	47,187,759	11.86%	Shares
BlackRock, Inc.	$184,618,217	50,304,691	11.34%	Shares
ARK Investment Management LLC	$151,709,111	41,337,632	9.32%	Shares
STATE STREET CORP	$127,371,497	34,706,130	7.82%	Shares
VANGUARD PORTFOLIO MANAGEMENT LLC	$114,252,968	31,131,599	7.02%	Shares
BAILLIE GIFFORD & CO	$86,200,618	23,487,907	5.30%	Shares
VANGUARD CAPITAL MANAGEMENT LLC	$83,551,000	22,765,940	5.13%	Shares
Kinnevik AB (publ)	$65,558,755	13,434,171	4.03%	Shares
GEODE CAPITAL MANAGEMENT, LLC	$50,724,628	13,819,135	3.12%	Shares
SOFTBANK GROUP CORP.	$50,046,010	13,636,515	3.07%	Shares
MIC Capital Management UK LLP	$35,393,601	9,644,033	2.17%	Shares
UBS Group AG	$32,835,865	8,947,102	2.02%	Shares
NORGES BANK	$25,079,070	6,833,534	1.54%	Shares
Data Collective IV GP, LLC	$21,803,910	5,941,120	1.34%	Shares
Sumitomo Mitsui Trust Group, Inc.	$20,227,891	5,511,687	1.24%	Shares
Amova Asset Management Americas, Inc.	$20,227,891	5,511,687	1.24%	Shares
NORTHERN TRUST CORP	$17,462,727	4,758,236	1.07%	Shares
MARSHALL WACE, LLP	$17,302,499	4,714,577	1.06%	Shares
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	$15,187,510	4,138,286	0.93%	Shares
DCVC Opportunity Fund II GP, LLC	$14,500,687	3,951,141	0.89%	Shares
GOLDMAN SACHS GROUP INC	$14,378,538	3,917,858	0.88%	Shares
VANGUARD FIDUCIARY TRUST CO	$12,736,948	3,470,558	0.78%	Shares
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	$12,351,832	4,023,398	0.76%	Shares
TWO SIGMA INVESTMENTS, LP	$12,307,925	3,353,658	0.76%	Shares
SUSQUEHANNA INTERNATIONAL GROUP, LLP	$12,286,059	3,347,700	0.75%	Call option
SUSQUEHANNA INTERNATIONAL GROUP, LLP	$12,082,110	3,292,128	0.74%	Shares
FIRST TRUST ADVISORS LP	$11,163,512	3,041,829	0.69%	Shares
MORGAN STANLEY	$10,068,644	2,743,499	0.62%	Shares
IQ EQ FUND MANAGEMENT (IRELAND) Ltd	$9,557,843	2,604,317	0.59%	Shares
BANK OF AMERICA CORP /DE/	$9,532,744	2,597,478	0.59%	Shares
Lingotto Investment Management LLP	$8,098,446	2,206,661	0.50%	Shares
MILLENNIUM MANAGEMENT LLC	$6,733,577	1,834,762	0.41%	Shares
Nuveen, LLC	$6,316,635	1,721,154	0.39%	Shares
Bank of New York Mellon Corp	$6,015,742	1,639,167	0.37%	Shares
SUSQUEHANNA INTERNATIONAL GROUP, LLP	$5,149,377	1,403,100	0.32%	Put option
CITADEL ADVISORS LLC	$4,779,808	1,302,400	0.29%	Call option
JPMORGAN CHASE & CO	$4,316,647	1,146,516	0.27%	Shares
CITADEL ADVISORS LLC	$4,072,232	1,109,600	0.25%	Put option
Jump Financial, LLC	$3,740,365	1,019,173	0.23%	Shares
Quadrature Capital Ltd	$3,625,219	987,798	0.22%	Shares
Swiss National Bank	$3,459,342	942,600	0.21%	Shares
Comprehensive Financial Management LLC	$3,456,755	941,895	0.21%	Shares
STIFEL FINANCIAL CORP	$3,234,974	881,457	0.20%	Shares
CITIGROUP INC	$3,172,359	864,403	0.19%	Shares
Invesco Ltd.	$2,920,211	795,698	0.18%	Shares
GROUP ONE TRADING LLC	$2,873,738	783,035	0.18%	Shares
Man Group plc	$2,810,435	765,786	0.17%	Shares
NATIONAL BANK OF CANADA /FI/	$2,714,446	739,631	0.17%	Shares
BNP PARIBAS ASSET MANAGEMENT Holding S.A.	$2,615,888	712,776	0.16%	Shares
Vestmark Advisory Solutions, Inc.	$2,601,509	708,858	0.16%	Shares

Show all 377 institutional owners →

Activists & 5%+ owners 2 positions

18

Investors who filed SEC Schedule 13D — beneficial ownership above 5% with an intent to influence the issuer (activist stakes, board campaigns, M&A). Each row shows the most recent known state of that filer's position.

Filer	Filed	Stake	Status	Purpose	Filing
Mubadala Investment Co PJSC, Mamoura Diversified Global Holding PJSC, MDC Capital Partners (Ventures) GP, LP, MDC Capital Partners (Ventures), LP, MIC Capital Management UK LLP, MC Alternative Solutions, LP, MIC Capital Partners (Ventures) Europe Parallel (Luxembourg) Aggregator SCSp	Dec. 23, 2025	1.40%	Amendment	·	SEC
Mubadala Investment Company PJSC, Mamoura Diversified Global Holdings PJSC, MDC Capital Partners (Ventures) GP, LP, MDC Capital Partners (Ventures), LP, MIC Capital Management UK LLP, MIC Capital Partners (Public) Parallel Cayman, LP ×3 filings	Oct. 31, 2022	·	Initial filing	·	SEC

Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.

Company insiders 19 insiders · 8 officers · 12 directors

19

Insider	Role	Last activity	Shares owned	Sells 12m	Net 12m
Najat Khan	CEO and President	Sept. 8, 2026 S	2,072,890	4	$-806,736
Ben R Taylor	Chief Financial Officer	Sept. 15, 2026 F	1,071,462	3	$-157,704
Michael Secora	Chief Financial Officer	Nov. 15, 2024 F	1,487,694	0	$0
Tina Marriott Larson	President and COO	Nov. 15, 2024 F	506,852	0	$0
David Hallett	Chief Scientific Officer	Aug. 17, 2026 F	1,043,837	0	$0
David J Mauro	Chief Medical Officer	Nov. 15, 2024 F	225,429	0	$0
Shafique Virani	Chief Business Officer	Jan. 16, 2024 M	136,748	0	$0
Ramona Doyle	Chief Medical Officer	May 16, 2022 F	121,110	0	$0
Zavain Dar	Director	Oct. 1, 2026 A	245,371	0	$0
Dean Y Li	Director	Oct. 1, 2026 A	1,476,707	0	$0
Blake Borgeson	Director	Sept. 1, 2026 S	6,158,287	10	$-4,097,900
Namandje Bumpus	Director	June 18, 2026 S	127,632	2	$-28,128
Franziska Michor	Director	June 17, 2026 A	215,477	0	$0
Elaine D Sun	Director	June 17, 2026 A	135,981	0	$0
Robert Hershberg	Director	June 17, 2026 A	162,156	0	$0
Christopher Gibson	Director	June 5, 2026 C	883,735	16	$-3,367,200
Terry-Ann Burrell	Director	July 1, 2024 A	71,254	0	$0
CHAVEZ R. MARTIN	Director	April 1, 2024 A	60,078	0	$0
Zachary Bogue	Director	July 3, 2023 A	9,378	0	$0

Insiders from SEC Form 3/4/5 filings; net = open-market P/S only

ETF ownership Held by 36 ETFs

20

Weight reflects direct equity holdings (N-PORT) only; leveraged or derivative-based funds may hold additional swap exposure not shown.

Fund	Weight	Units	As of	Source
ARKG · ARK ETF Trust	2.63%	13,638,907 NS	July 31, 2026	N-PORT
ARKK · ARK ETF Trust	1.09%	20,255,566 NS	July 31, 2026	N-PORT
BBC · ETFis Series Trust I	0.64%	98,670 NS	July 31, 2026	N-PORT
LABU · Direxion Shares ETF Trust	0.46%	750,099 NS	July 31, 2026	N-PORT
ESSC · Strategy Shares	0.25%	29,732 NS	July 31, 2026	N-PORT
IBBQ · Invesco Exchange-Traded Fund Trust …	0.15%	37,849 SH	Oct. 2, 2026	Daily
PWS · Pacer Funds Trust	0.13%	10,248 NS	July 31, 2026	N-PORT
VTWV · VANGUARD SCOTTSDALE FUNDS	0.11%	407,525 SH	Aug. 19, 2026	Daily
IBB · iShares Trust	0.11%	3,588,712 SH	Sept. 11, 2026	Daily
NUSC · Nushares ETF Trust	0.11%	457,697 NS	July 31, 2026	N-PORT
PRFZ · Invesco Exchange-Traded Fund Trust	0.10%	635,985 SH	Oct. 2, 2026	Daily
VTWO · VANGUARD SCOTTSDALE FUNDS	0.06%	2,943,069 SH	Aug. 19, 2026	Daily
BBSC · J.P. Morgan Exchange-Traded Fund Tr…	0.06%	136,281 NS	July 31, 2026	N-PORT
ESML · iShares Trust	0.05%	468,949 SH	Sept. 11, 2026	Daily
IWM · iShares Trust	0.05%	13,009,536 SH	Sept. 11, 2026	Daily
VBK · VANGUARD INDEX FUNDS	0.05%	6,619,812 SH	Aug. 19, 2026	Daily
RSSL · Global X Funds	0.05%	244,466 NS	July 31, 2026	N-PORT
DXUV · Dimensional ETF Trust	0.03%	55,703 NS	July 31, 2026	N-PORT
VHT · VANGUARD WORLD FUND	0.03%	1,414,694 SH	Aug. 19, 2026	Daily
FHLC · FIDELITY COVINGTON TRUST	0.02%	223,214 NS	July 31, 2026	N-PORT
VXF · VANGUARD INDEX FUNDS	0.02%	6,007,573 SH	Aug. 19, 2026	Daily
VB · VANGUARD INDEX FUNDS	0.02%	11,441,396 SH	Aug. 19, 2026	Daily
ISCG · iShares Trust	0.02%	53,314 SH	Sept. 11, 2026	Daily
WSML · iShares Trust	0.01%	29,464 SH	Sept. 11, 2026	Daily
VTWG · VANGUARD SCOTTSDALE FUNDS	0.01%	50,346 SH	Aug. 19, 2026	Daily
IWO · iShares Trust	0.01%	440,939 SH	Sept. 11, 2026	Daily
IWV · iShares Trust	0.00%	159,946 SH	Sept. 10, 2026	Daily
ITOT · iShares Trust	0.00%	725,350 SH	Sept. 11, 2026	Daily
TILT · FlexShares Trust	0.00%	474 NS	July 31, 2026	N-PORT
VTI · VANGUARD INDEX FUNDS	0.00%	15,827,859 SH	Aug. 19, 2026	Daily
VT · VANGUARD INTERNATIONAL EQUITY INDEX…	0.00%	420,023 SH	Aug. 19, 2026	Daily
VTHR · VANGUARD SCOTTSDALE FUNDS	0.00%	43,429 SH	Aug. 19, 2026	Daily
ESGV · VANGUARD WORLD FUND	0.00%	113,259 SH	Aug. 19, 2026	Daily
IWN · iShares Trust	·	4,339,698 SH	Sept. 11, 2026	Daily
ISCB · iShares Trust	·	23,036 SH	Sept. 11, 2026	Daily
ISCV · iShares Trust	·	77,921 SH	Sept. 11, 2026	Daily

RXRX Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside

21

rating · 13 analysts BUY

Median target $7.00 +69.9%

2 15.4% Strong Buy

6 46.2% Buy

5 38.5% Hold

0 0.0% Sell

0 0.0% Strong Sell

12-Month Price Target

6 analysts · 2026-10-03

Mean target $7.22 +75.2%

Now Current price $4.12

Low$4.00 Mean$7.22 High$10.00

Peer comparison (GICS sub-industry) Key metrics vs sector peers

22

FY basis, prices as of each company's last fiscal year-end close.

Ticker	Market Cap	P/E	Rev YoY	Net Margin	ROE	Gross Margin
RXRX	$2.16B	-2.8	26.9%	-863.4%	-62.9%	·
NRIX	$1.80B	-5.8	53.9%	-314.9%	-53.6%	·
IMNM	$2.43B	-8.8	-23.2%	-3060.0%	-47.0%	·
SLS	$577M	-15.1	·	·	-55.4%	·
VRDN	$3.17B	-7.7	23359.9%	-483.6%	-55.4%	·
VERA	·	-10.9	·	·	-55.9%	·
ADMA	$4.34B	30.4	19.6%	28.8%	33.6%	57.4%
MLYS	$2.96B	-15.8	·	·	-32.2%	·
BCRX	$1.66B	6.4	94.1%	30.2%	-97.6%	·
VCEL	$1.82B	112.5	16.4%	6.0%	5.0%	74.4%

Latest News Recent headlines mentioning this company

23

Morgan Stanley Raises its Price Target on Recursion (RXRX) Yahoo Finance · 4 months, 1 week ago

My Metrics Your personal watchlist — selected rows from Full Fundamentals

26

Pick the metrics that matter to you — click the + next to any row in Full Fundamentals above.

Your selection is saved and follows you across all tickers.

RXRX Class A Recursion Pharmaceuticals, Inc. - Class A Common Stock